home / stock / tenx / tenx news


TENX News and Press, Tenax Therapeutics Inc. From 02/06/24

Stock Information

Company Name: Tenax Therapeutics Inc.
Stock Symbol: TENX
Market: NASDAQ
Website: tenaxthera.com

Menu

TENX TENX Quote TENX Short TENX News TENX Articles TENX Message Board
Get TENX Alerts

News, Short Squeeze, Breakout and More Instantly...

TENX - Tenax surges after patent win for heart failure therapy

2024-02-06 13:37:49 ET More on Tenax Therapeutics Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Seeking Alpha’s Quant Rating on Tenax Therapeutics Historical earnings data ...

TENX - Tenax Therapeutics Inc. (NASDAQ: TENX) Near the Top of Equities by Percentage Gain on 2/6

Tenax Therapeutics, Inc. (NASDAQ: TENX) is one of today's top gainers. The company's shares have moved 82.38% on the day to $15.94. Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary di...

TENX - Biotech stock Tenax Therapeutics more than doubled on Tuesday

2024-02-06 10:01:21 ET Tenax Therapeutic Inc (NASDAQ: TENX) opened nearly 150% up this morning after receiving approval for a patent application. Tenax Therapeutics stock rallies ahead of earnings The U.S. Patent and Trademark Office accepted its patent application for levosimen...

TENX - Madrigal Pharmaceuticals, Cerus among healthcare movers

2024-02-06 10:00:02 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Lilly, Zoetis, Abbott least shor...

TENX - Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly Broadening IP Protection for Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

Once granted, this patent will: provide U.S. intellectual property (IP) protection until December 2040, and may qualify for additional U.S. patent term extension (PTE) beyond 2040 broaden IP protection for oral (TNX-103), IV, and subcutaneous use of levosimendan, and its active ...

TENX - (TENX) Technical Pivots with Risk Controls

2024-01-25 12:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

TENX - TENX, TAOP and AISP among mid-day movers

2024-01-03 12:43:51 ET More on Mid-day movers & stocks. Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Financial information for Airship AI Holdings, Inc. Financial information...

TENX - TENX announced stock split 1-80

2024-01-02 08:02:09 ET Tenax Therapeutics Inc (TENX) announced stock split at a ratio of 1-for-80 on 2024-01-03 ... Full story available on KlickAnalytics.com

TENX - Tenax Therapeutics announces reverse stock split

2023-12-29 08:35:01 ET More on Tenax Therapeutics Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Seeking Alpha’s Quant Rating on Tenax Therapeutics Historical earnings data ...

TENX - Tenax Therapeutics files to sell ordinary shares, warrants

2023-12-04 06:55:43 ET More on Tenax Therapeutics Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Seeking Alpha’s Quant Rating on Tenax Therapeutics Historical earnings data ...

Previous 10 Next 10